Variation in performance of candidate surgical quality measures for muscle-invasive bladder cancer by hospital type

BJU International

Volumn 115, Issue 2, 2015, Pages 230-237

  Corcoran, Anthony T ^a   Handorf, Elizabeth ^a   Canter, Daniel ^b   Tomaszewski, Jeffrey J ^a   Bekelman, Justin E ^c   Kim, Simon P ^d   Uzzo, Robert G ^a   Kutikov, Alexander ^a   Smaldone, Marc C ^a  

^a TEMPLE UNIVERSITY HEALTH SYSTEM   (United States)

^b ALBERT EINSTEIN MEDICAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d MAYO CLINIC   (United States)

Author keywords

bladder cancer; hospital type; quality measures; radical cystectomy; surgical volume

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER REGISTRY; COMMUNITY HOSPITAL; CYSTECTOMY; FEMALE; HEALTH CARE QUALITY; HIGH VOLUME HOSPITAL; HUMAN; LOW VOLUME HOSPITAL; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MUSCLE INVASIVE BLADDER CANCER; TEACHING HOSPITAL; TRANSITIONAL CELL CARCINOMA; UNITED STATES; URINARY DIVERSION; CLINICAL TRIAL; EPIDEMIOLOGY; HEALTH CARE FACILITY; HOSPITAL; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MUSCLE NEOPLASMS; NEOADJUVANT THERAPY; PATHOLOGY; PROGNOSIS; REGISTER; SECONDARY; STANDARDS; STATISTICS AND NUMERICAL DATA; TOTAL QUALITY MANAGEMENT; TUMOR INVASION; URINARY BLADDER NEOPLASMS; VERY ELDERLY;

ANTINEOPLASTIC AGENT;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CYSTECTOMY; FEMALE; HEALTH FACILITY SIZE; HOSPITALS; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; MUSCLE NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; PROGNOSIS; QUALITY IMPROVEMENT; QUALITY OF HEALTH CARE; REGISTRIES; UNITED STATES; URINARY BLADDER NEOPLASMS; URINARY DIVERSION;

EID: 84921602541     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12638     Document Type: Article

References (32)

1. McWilliams JM, Landon BE, Chernew ME,. Changes in health care spending and quality for Medicare beneficiaries associated with a commercial ACO contract. JAMA 2013; 310: 829-836
2. Renzi C, Sorge C, Fusco D, Agabiti N, Davoli M, Perucci CA,. Reporting of quality indicators and improvement in hospital performance: the P.Re.Val.E. Regional Outcome Evaluation Program. Health Serv Res 2012; 47: 1880-1901
3. Ketelaar NA, Faber MJ, Flottorp S, Rygh LH, Deane KH, Eccles MP,. Public release of performance data in changing the behaviour of healthcare consumers, professionals or organisations. Cochrane Database Syst Rev 2011; (11): CD004538
4. Carlsen B, Glenton C, Pope C,. Thou shalt versus thou shalt not: a meta-synthesis of GPs' attitudes to clinical practice guidelines. Br J Gen Pract 2007; 57: 971-978
5. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30
6. Hollenbeck BK, Wei Y, Birkmeyer JD,. Volume, process of care, and operative mortality for cystectomy for bladder cancer. Urology 2007; 69: 871-875
7. Chamie K, Saigal CS, Lai J, et al. Compliance with guidelines for patients with bladder cancer: variation in the delivery of care. Cancer 2011; 117: 5392-5401
8. Corcoran AT, Smaldone MC, Kutikov A, Uzzo RG,. Addressing the evidence gap-randomized controlled trials for the surgical management of localized genitourinary malignancies. Urol Oncol Semin Orig Invest 2013; 31: 393-397
9. Cooperberg MR, Porter MP, Konety BR,. Candidate quality of care indicators for localized bladder cancer. Urol Oncol 2009; 27: 435-442
10. Birkmeyer JD, Dimick JB,. Potential benefits of the new Leapfrog standards: effect of process and outcomes measures. Surgery 2004; 135: 569-575
11. Winchester DP, Stewart AK, Bura C, Jones RS,. The National Cancer Data Base: a clinical surveillance and quality improvement tool. J Surg Oncol 2004; 85: 1-3
12. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346: 1128-1137
13. Elting LS, Pettaway C, Bekele BN, et al. Correlation between annual volume of cystectomy, professional staffing, and outcomes: a statewide, population-based study. Cancer 2005; 104: 975-984
14. Bilimoria KY, Bentrem DJ, Talamonti MS, Stewart AK, Winchester DP, Ko CY,. Risk-based selective referral for cancer surgery: a potential strategy to improve perioperative outcomes. Ann Surg 2010; 251: 708-716
15. Chassin MR, Loeb JM,. The ongoing quality improvement journey: next stop, high reliability. Health Aff (Millwood) 2011; 30: 559-568
16. Birkmeyer NJ, Birkmeyer JD,. Strategies for improving surgical quality-should payers reward excellence or effort? N Engl J Med 2006; 354: 864-870
17. Hollenbeck BK, Montie JE, Wei JT,. Radical cystectomy and surgical quality of care. J Natl Compr Canc Netw 2005; 3: 37-42
18. Donabedian A,. Evaluating the quality of medical care. Milbank Mem Fund Q 1966; 44 (Suppl.): 166-206
19. Shojania KG, Grimshaw JM,. Evidence-based quality improvement: the state of the science. Health Aff (Millwood) 2005; 24: 138-150
20. Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003; 349: 859-866
21. Gore JL, Lai J, Setodji CM, Litwin MS, Saigal CS, Urologic Diseases in America P,. Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance. Epidemiol End Results Medicare Anal Cancer 2009; 115: 988-996
22. Hollenbeck BK, Ye Z, Wong SL, Montie JE, Birkmeyer JD,. Hospital lymph node counts and survival after radical cystectomy. Cancer 2008; 112: 806-812
23. Nabi G, Yong SM, Ong E, McPherson G, Grant A, N'Dow J,. Is orthotopic bladder replacement the new gold standard? Evidence from a systematic review. J Urol 2005; 174: 21-28
24. Malin JL, Schneider EC, Epstein AM, Adams J, Emanuel EJ, Kahn KL,. Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? J Clin Oncol 2006; 24: 626-634
25. Stitzenberg KB, Sigurdson ER, Egleston BL, Starkey RB, Meropol NJ,. Centralization of cancer surgery: implications for patient access to optimal care. J Clin Oncol 2009; 27: 4671-4678
26. Koppie TM, Vickers AJ, Vora K, Dalbagni G, Bochner BH,. Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Cancer 2006; 107: 2368-2374
27. Fang AC, Ahmad AE, Whitson JM, Ferrell LD, Carroll PR, Konety BR,. Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer. Cancer 2010; 116: 1901-1908
28. Cody JD, Nabi G, Dublin N, et al. Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy. Cochrane Database Syst Rev 2012; (2): CD003306
29. Gore JL, Saigal CS, Hanley JM, Schonlau M, Litwin MS,. Variations in reconstruction after radical cystectomy. Cancer 2006; 107: 729-737
30. Kagawa-Singer M, Dadia AV, Yu MC, Surbone A,. Cancer, culture, and health disparities: time to chart a new course? CA Cancer J Clin 2010; 60: 12-39
31. Sullivan R, Peppercorn J, Sikora K, et al. Delivering affordable cancer care in high-income countries. Lancet Oncol 2011; 12: 933-980
32. Goossens-Laan CA, Gooiker GA, van Gijn W, et al. A systematic review and meta-analysis of the relationship between hospital/surgeon volume and outcome for radical cystectomy: an update for the ongoing debate. Eur Urol 2011; 59: 775-783